EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-221307
Abstract: Background Comparing treatment effectiveness over time in observational settings is hampered by several major threats, among them confounding and attrition bias. Objectives To develop European Alliance of Associations for Rheumatology (EULAR) points to consider (PtC)… read more here.
Keywords: eular points; comparative effectiveness; effectiveness; points consider ... See more keywords
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2022-222155
Abstract: Objective To develop EULAR points-to-consider for therapeutic drug monitoring (TDM) of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases (RMDs). Methods The points-to-consider were developed in accordance with EULAR standardised operation procedures by a multidisciplinary task… read more here.
Keywords: tdm; therapeutic drug; consider therapeutic; points consider ... See more keywords
EULAR ‘points to consider’ for the conduction of workforce requirement studies in rheumatology
Sign Up to like & getrecommendations! Published in 2018 at "RMD Open"
DOI: 10.1136/rmdopen-2018-000780
Abstract: Objective Current methods used for forecasting workforce requirements in rheumatology are disparate, as are the parameters incorporated into workforce projection studies. The objective of these European League Against Rheumatism (EULAR points to consider (PTC) is… read more here.
Keywords: workforce; requirement studies; workforce requirement; points consider ... See more keywords